Copaxone bald nur noch einmal im Monat?

4 posts in this topic

Endlich mal wieder brauchbare Ergebnisse aus der MS Forschung....

...Phase III trial for the company’s lead product, Glatiramer Acetate (Copaxone®) Depot, or GA Depot, for the treatment of multiple sclerosis (MS). Mapi Pharma recently completed a successful Phase II, open-label, two arm, multicenter, study to assess safety, tolerability, and efficacy of once-a-month, long-acting IM (intramuscular) injection of 80mg or 40mg glatiramer acetate in patients with relapsing remitting multiple sclerosis (RRMS)...

..dann gibt's demnächst Copaxone als monatliche Fertigspritze..



Share this post

Link to post
Share on other sites

Mich wundert allerdings die geringe Dosierung, selbst bei intramuskulärer Injektion.

Share this post

Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now